FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2762426797> ?p ?o ?g. }

• W2762426797 endingPage "1098" @default.
• W2762426797 startingPage "1093" @default.
• W2762426797 abstract "Introduction: In the last decade tyrosine kinase inhibitors (TKIs) have been employed for a wide range of hematological and solid tumors and today they represent a valid therapeutic option for different neoplasms. Among them, both sorafenib and lenvatinib were approved for the treatment of radioactive iodine (RAI) refractory differentiated thyroid carcinoma (DTC). Unfortunately, in some cases the efficacy of TKIs is limited by the onset of drug resistance after the initial response.Areas covered: We report the case of a patient with a RAI refractory advanced DTC, treated with lenvatinib after surgery, multiple RAI administrations, traditional chemotherapy, and sorafenib. During treatment with lenvatinib, a noticeable response was detected by sequential computed tomography scans but, after 27 months, tumor progression became evident and led to lenvatinib interruption. In absence of any active treatment, a further disease progression was documented, and lenvatinib was re-administered obtaining a new objective response. Starting from this case report, we review available reports about the rechallenge with TKIs in solid tumors, discussing the possible mechanisms underlying the efficacy of this approach.Expert commentary: Rechallenge with TKIs in solid tumors could be a therapeutic option in subjects with advanced and metastatic DTC who experience a progressive disease after initial response to lenvatinib." @default.
• W2762426797 created "2017-10-20" @default.
• W2762426797 creator A5000989087 @default.
• W2762426797 creator A5011539967 @default.
• W2762426797 creator A5023916807 @default.
• W2762426797 creator A5026404310 @default.
• W2762426797 creator A5044433188 @default.
• W2762426797 creator A5075387437 @default.
• W2762426797 creator A5076643968 @default.
• W2762426797 date "2017-10-13" @default.
• W2762426797 modified "2023-10-14" @default.
• W2762426797 title "Tyrosine kinase inhibitors rechallenge in solid tumors: a review of literature and a case description with lenvatinib in thyroid cancer" @default.
• W2762426797 cites W1498185347 @default.
• W2762426797 cites W178555968 @default.
• W2762426797 cites W1967431262 @default.
• W2762426797 cites W1967550842 @default.
• W2762426797 cites W1967792499 @default.
• W2762426797 cites W1976056806 @default.
• W2762426797 cites W1978304226 @default.
• W2762426797 cites W1982326378 @default.
• W2762426797 cites W1984941031 @default.
• W2762426797 cites W1990378122 @default.
• W2762426797 cites W1994669778 @default.
• W2762426797 cites W2006262863 @default.
• W2762426797 cites W2019607817 @default.
• W2762426797 cites W2040642592 @default.
• W2762426797 cites W2044510096 @default.
• W2762426797 cites W2045992174 @default.
• W2762426797 cites W2056115376 @default.
• W2762426797 cites W2064195069 @default.
• W2762426797 cites W2078020286 @default.
• W2762426797 cites W2089971534 @default.
• W2762426797 cites W2096540669 @default.
• W2762426797 cites W2106130856 @default.
• W2762426797 cites W2113375488 @default.
• W2762426797 cites W2145150141 @default.
• W2762426797 cites W2147723172 @default.
• W2762426797 cites W2157096649 @default.
• W2762426797 cites W2168076926 @default.
• W2762426797 cites W2387280626 @default.
• W2762426797 cites W2400741439 @default.
• W2762426797 cites W2590696821 @default.
• W2762426797 cites W2999408491 @default.
• W2762426797 doi "https://doi.org/10.1080/14737140.2017.1390432" @default.
• W2762426797 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28988510" @default.
• W2762426797 hasPublicationYear "2017" @default.
• W2762426797 type Work @default.
• W2762426797 sameAs 2762426797 @default.
• W2762426797 citedByCount "19" @default.
• W2762426797 countsByYear W27624267972018 @default.
• W2762426797 countsByYear W27624267972019 @default.
• W2762426797 countsByYear W27624267972020 @default.
• W2762426797 countsByYear W27624267972021 @default.
• W2762426797 countsByYear W27624267972022 @default.
• W2762426797 countsByYear W27624267972023 @default.
• W2762426797 crossrefType "journal-article" @default.
• W2762426797 hasAuthorship W2762426797A5000989087 @default.
• W2762426797 hasAuthorship W2762426797A5011539967 @default.
• W2762426797 hasAuthorship W2762426797A5023916807 @default.
• W2762426797 hasAuthorship W2762426797A5026404310 @default.
• W2762426797 hasAuthorship W2762426797A5044433188 @default.
• W2762426797 hasAuthorship W2762426797A5075387437 @default.
• W2762426797 hasAuthorship W2762426797A5076643968 @default.
• W2762426797 hasConcept C121332964 @default.
• W2762426797 hasConcept C121608353 @default.
• W2762426797 hasConcept C126322002 @default.
• W2762426797 hasConcept C142424586 @default.
• W2762426797 hasConcept C143998085 @default.
• W2762426797 hasConcept C170493617 @default.
• W2762426797 hasConcept C2776264508 @default.
• W2762426797 hasConcept C2778019345 @default.
• W2762426797 hasConcept C2778695046 @default.
• W2762426797 hasConcept C2779761222 @default.
• W2762426797 hasConcept C42362537 @default.
• W2762426797 hasConcept C71924100 @default.
• W2762426797 hasConcept C87355193 @default.
• W2762426797 hasConceptScore W2762426797C121332964 @default.
• W2762426797 hasConceptScore W2762426797C121608353 @default.
• W2762426797 hasConceptScore W2762426797C126322002 @default.
• W2762426797 hasConceptScore W2762426797C142424586 @default.
• W2762426797 hasConceptScore W2762426797C143998085 @default.
• W2762426797 hasConceptScore W2762426797C170493617 @default.
• W2762426797 hasConceptScore W2762426797C2776264508 @default.
• W2762426797 hasConceptScore W2762426797C2778019345 @default.
• W2762426797 hasConceptScore W2762426797C2778695046 @default.
• W2762426797 hasConceptScore W2762426797C2779761222 @default.
• W2762426797 hasConceptScore W2762426797C42362537 @default.
• W2762426797 hasConceptScore W2762426797C71924100 @default.
• W2762426797 hasConceptScore W2762426797C87355193 @default.
• W2762426797 hasFunder F4320322148 @default.
• W2762426797 hasIssue "12" @default.
• W2762426797 hasLocation W27624267971 @default.
• W2762426797 hasLocation W27624267972 @default.
• W2762426797 hasOpenAccess W2762426797 @default.
• W2762426797 hasPrimaryLocation W27624267971 @default.
• W2762426797 hasRelatedWork W1933195344 @default.
• W2762426797 hasRelatedWork W2339653204 @default.
• W2762426797 hasRelatedWork W2433065005 @default.

• next